NCT07077512 2026-01-21Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell LymphomaSun Yat-sen UniversityPhase 2 Recruiting30 enrolled
NCT04545762 2026-01-14Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin LymphomaUniversity of California, San FranciscoPhase 1 Recruiting36 enrolled